P-100 A phase II study of first-line chemotherapy initiating FOLFIRI+cetuximab and switching to FOLFIRI+bevacizumab according to early tumor shrinkage at 8 weeks in RAS wild-type metastatic colorectal cancer: HYBRID trial
Autor: | Hirokazu Shoji, F. Mizuki, Takuro Mizukami, Masahito Kotaka, Yu Sunakawa, K. Danenberg, Yusuke Nagata, Takako Eguchi Nakajima, Kohei Akiyoshi, Takashi Tsuda, S. Tokunaga, Kenji Kunieda, Narikazu Boku, Toshihiko Matsumoto, Mototsugu Shimokawa |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Annals of Oncology. 32:S132 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |